European Society of Cardiology Quality Indicators for Cardiovascular Disease Prevention: developed by the Working Group for Cardiovascular Disease Prevention Quality Indicators in collaboration with the European Association for Preventive Cardiology of the European Society of Cardiology-Reference-Cited by-同舟云学术

European Society of Cardiology Quality Indicators for Cardiovascular Disease Prevention: developed by the Working Group for Cardiovascular Disease Prevention Quality Indicators in collaboration with the European Association for Preventive Cardiology of the European Society of Cardiology

Published:2021-10-23 Issue: Volume: Page:
ISSN:2047-4873
Container-title:European Journal of Preventive Cardiology
language:en
Short-container-title:

Author:

Aktaa Suleman¹²³^ORCID,Gencer Baris⁴⁵,Arbelo Elena⁶⁷⁸^ORCID,Davos Constantinos H⁹^ORCID,Désormais Ileana¹⁰,Hollander Monika¹¹,Abreu Ana¹²,Ambrosetti Marco¹³,Bäck Maria¹⁴¹⁵,Carballo David¹⁶,Crawford Carolyn¹⁷,Deaton Christi¹⁸^ORCID,Dendale Paul¹⁹^ORCID,Eijsvogels Thijs M H²⁰,Galbraith Mary¹⁷,Piepoli Massimo Francesco²¹,Salzwedel Annett²²,Smulders Yvo²³,Wilhelm Matthias²⁴,Biondi-Zoccai Giuseppe²⁵²⁶^ORCID,Mach François⁴^ORCID,Visseren Frank L J²⁷,Gale Chris P¹²³

Affiliation:

1. Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds LS2 9LU, UK

2. Leeds Institute for Data Analytics, University of Leeds, Leeds LS2 9LU, UK

3. Department of Cardiology, Leeds Teaching Hospitals NHS Trust, Leeds, UK

4. Division of Cardiology, Department of Medicine, Geneva University Hospitals, Geneva, Switzerland

5. Institute of Primary Health Care (BIHAM), University of Bern, Bern, Switzerland

6. Arrhythmia Section, Cardiology Department, Hospital Clínic, Universitat de Barcelona, Barcelona, Spain

7. IDIBAPS, Institut d’Investigació August Pi i Sunyer (IDIBAPS), Barcelona, Spain

8. Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain

9. Cardiovascular Research Laboratory, Biomedical Research Foundation, Academy of Athens, Athens, Greece

10. Department of Thoracic and Cardiovascular Surgery and Angiology, Dupuytren University Hospital, Limoges, France

11. Department of General Practice, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Universiteitsweg 100, Utrecht 3584 CG, The Netherlands

12. Cardiology Department, Hospital Santa Maria, Centro Hospitalar Universitário Lisboa Norte, (CHULN) Lisboa, Lisbon, Portugal

13. Cardiovascular Rehabilitation Unit, ASST Crema, Rivolta D’Adda Hospital, Rivolta D' Adda, Italy

14. Unit of Physiotherapy, Department of Health, Medicine and Caring Sciences, Linköping University, Linköping, Sweden

15. Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, and Sahlgrenska University Hospital, Gothenburg, Sweden

16. Department of Cardiology, Cardiovascular Center, University Hospital Geneva, Rue Gabrielle-Perret-Gentil 4, Geneva 1205, Switzerland

17. ESC Patient Forum, Sophia Antipolis, France

18. Department of Public Health and Primary Care, University of Cambridge School of Clinical Medicine, Forvie Site, Cambridge Biomedical Campus, Cambridge CB22 5DT, UK

19. Heart Centre Hasselt and Faculty of Medicine and Life Sciences, Hasselt University, Hasselt, Belgium

20. Department of Physiology, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands

21. Heart Failure Unit, Cardiology, Guglielmo da Saliceto Hospital, and University pof Parma, Piacenza, Italy

22. Department of Rehabilitation Medicine, Faculty of Health Sciences Brandenburg, University of Potsdam, Potsdam, Germany

23. Department of Internal Medicine and Geriatrics, Amsterdam UMC, Location VUmc, Amsterdam, the Netherlands

24. Department of Cardiology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland

25. Department of Medical-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Latina, Italy

26. Mediterranea Cardiocentro, Napoli, Italy

27. Department of Vascular Medicine, University Medical Center Utrecht, Utrecht University, Utrecht, Utrecht, The Netherlands

Abstract

Abstract Aims To develop a set of quality indicators (QIs) for the evaluation of the care and outcomes for atherosclerotic cardiovascular disease (ASCVD) prevention. Methods and results The Quality Indicator Committee of the European Society of Cardiology (ESC) formed the Working Group for Cardiovascular Disease Prevention Quality Indicators in collaboration with Task Force members of the 2021 ESC Guidelines on Cardiovascular Disease Prevention in Clinical Practice and the European Association of Preventive Cardiology (EAPC). We followed the ESC methodology for QI development, which involved (i) the identification of the key domains of care for ASCVD prevention by constructing a conceptual framework of care, (ii) the development of candidate QIs by conducting a systematic review of the literature, (iii) the selection of the final set of QIs using a modified Delphi method, and (iv) the evaluation of the feasibility of the developed QIs. In total, 17 main and 14 secondary QIs were selected across six domains of care for ASCVD prevention: (i) structural framework, (ii) risk assessment, (iii) care for people at risk for ASCVD, (iv) care for patients with established ASCVD, (v) patient education and experience, and (vi) outcomes. Conclusion We present the 2021 ESC QIs for Cardiovascular Disease Prevention, which have been co-constructed with EAPC using the ESC methodology for QI development. These indicators are supported by evidence from the literature, underpinned by expert consensus and aligned with the 2021 ESC Guidelines on Cardiovascular Disease Prevention in Clinical Practice to offer a mechanism for the evaluation of ASCVD prevention care and outcomes.

Funder

European Society of Cardiology

Publisher

Oxford University Press (OUP)

Subject

Cardiology and Cardiovascular Medicine,Epidemiology

Link

http://academic.oup.com/eurjpc/advance-article-pdf/doi/10.1093/eurjpc/zwab160/40832853/zwab160.pdf

Reference48 articles.

1. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019;GBD 2019 Diseases and Injuries Collaborators;Lancet,2020

2. Trends in diabetes treatment and control in U.S. adults, 1999–2018;Fang;N Engl J Med,2021

3. Determinants of participation and risk factor control according to attendance in cardiac rehabilitation programmes in coronary patients in Europe: EUROASPIRE IV survey;Kotseva;Eur J Prev Cardiol,2018